| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.029 | 0.9 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.9 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.026 | 0.9 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.0083 | 0.9 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |